HS
EW icon

Haafor (Singapore)’s Edwards Lifesciences EW Stock Holding History

Haafor (Singapore)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$864K Buy
9,466
+1,728
+22% +$143K 1.61% 6
2020
Q3 		$619K Sell
7,738
-1,746
-18% -$136K 1.29% 10
2020
Q2 		$655K Buy
9,484
+637
+7% +$45.3K 1.12% 19
2020
Q1 		$556K Buy
8,847
+1,596
+22% +$115K 0.89% 21
2019
Q4 		$564K Buy
+7,251
New +$566K 0.37% 85

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Haafor (Singapore)'s EW Position: Q4 2020 in Review

Haafor (Singapore) increased its Edwards Lifesciences (EW) stake by 22% in Q4 2020, buying an estimated $143K and bringing the position to 9,466 shares worth $864K. The position accounts for 1.61% of the portfolio, ranked #6.

Haafor (Singapore) first reported a position in EW in Q4 2019 and has held it in 5 quarters since. 1,160 funds tracked by Wall St. Rank hold EW as of Q4 2020.

  • Haafor (Singapore) held 9,466 shares of Edwards Lifesciences worth $864K as of Q4 2020.
  • Haafor (Singapore) bought 1,728 Edwards Lifesciences shares in Q4 2020, an estimated $143K.
  • Edwards Lifesciences made up 1.61% of Haafor (Singapore)'s portfolio in Q4 2020, its #6 holding.
  • Haafor (Singapore) first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 5 quarters since.
  • 1,160 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2020.

Based on Haafor (Singapore)'s 13F filing for Q4 2020, filed 5 Feb 2021.